Abstract
Klebsiella pneumoniae is a member of the family Enterobacteriaceae, opportunistic pathogens that are among the eight most prevalent infectious agents in hospitals. The emergence of multidrug-resistant strains of K. pneumoniae has became a public health problem globally. To develop an effective antimicrobial agent, we isolated a bacteriophage, named JD001, from seawater and sequenced its genome. Comparative genome analysis of phage JD001 with other K. pneumoniae bacteriophages revealed that phage JD001 has little similarity to previously published K. pneumoniae phages KP15, KP32, KP34, and phiKO2. Here we announce the complete genome sequence of JD001 and report major findings from the genomic analysis.
GENOME ANNOUNCEMENT
Klebsiella pneumoniae is an important opportunistic pathogen that causes hospital-acquired pneumonia, sepsis, and urinary tract infections. Multidrug resistance is emerging worldwide among K. pneumoniae strains at an alarming rate and raises the problem of antibiotic choice (2, 7). It sometimes causes severe infection, and some of the infectious diseases caused by antibiotic-resistant bacteria cannot be treated in time (5). The use of bacteriophages to treat some infectious diseases was tried once they were discovered (1, 6). To develop bacteriophage cocktails as an alternative biocontrol agent for K. pneumoniae, K. pneumoniae phages have been isolated by using K. pneumoniae clinical isolates as the host organisms in our group. A novel K. pneumoniae phage, JD001, were isolated from a seawater sample collected at an estuary of the East China Sea near Shanghai, China. It belongs to the Myoviridae family, according the transmission electron microscopic image, and efficiently lyses K. pneumoniae strain JDM777, which was isolated in a hospital.
The bacteriophage was purified by discontinuous CsCl centrifugation, and phage genomic DNA was extracted by using the Aidlab kit (Aidlab Biotechnologies Co., Ltd.). It was sequenced by using the Roche 454 genome sequencer at the Chinese National Human Genome Center in Shanghai. The assembly of quality filtered reads was performed by using the platform the 454 Life Sciences Corporation provided, and the prediction of open reading frames (ORFs) and their confirmation were conducted by using GLIMMER (3) and GeneMark.hmm (9), respectively. Conserved protein domain analysis of predicted ORFs was also carried out by using the BLASTP nr database and InterProScan programs (10). tRNA was predicted by the use of tRNAscan-SE software (8).
The complete circular double-stranded DNA genome of K. pneumoniae phage JD001 showed a 48,814-bp length with a GC content of 48.53%. The genome sequences of JD001 had little similarity to those of previously published K. pneumoniae phages KP15, KP32, KP34, and phiKO2 (4). There were 68 predicted ORFs and no tRNA, and 40 of the ORFs encode hypothetical proteins. The others were expected to encode proteins with conserved domains or similarity to a pectate lyase, DNA/RNA polymerases, a helicase, a tetracycline transcriptional regulator, an integrase, an endonuclease, metallo-dependent phosphatases, a terminase, a J-like baseplate assembly protein, a phage head morphogenesis domain, a tail spike protein (gluconolactonase), a prophage protein, and some phage-related proteins whose functions are still unknown. In addition, ORF JD001-59, which is predicted to encode a lysozyme, has 54% identity to previously published data.
Overall, the genome sequences of JD001 had little similarity to previously published K. pneumoniae phages KP15, KP32, KP34. and phiKO2 (4). These genome data constitute an important resource for us to study and engineer phages or the lysozyme they encode to control specific bacterial species.
Nucleotide sequence accession number.
The whole genome sequence of K. pneumoniae phage JD001 has been deposited in GenBank under accession no. JX866719.
ACKNOWLEDGMENTS
This work was supported in part by the National Natural Science Foundation of China (grants 81261160321, 81201334, 81171587, 81271793, 30970125, 81200265, and 30900051), the National High Technology Research and Development Program of China (grant number 2011AA02A119), Youth fund of Shanghai Health Bureau (grant number 2011Y168), the China Postdoctoral Sustentation Fund (grant number 2011M500605), and the National Key Program for Infectious Diseases of China (grant 2009ZX10004-712).
REFERENCES
- 1. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. 2011. Phage treatment of human infections. Bacteriophage 1:66–85 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-beta-lactamases: a last frontier for beta-lactams? Lancet Infect. Dis. 11:381–393 [DOI] [PubMed] [Google Scholar]
- 3. Delcher AL, Harmon D, Kasif S, White O, Salzberg SL. 1999. Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 27:4636–4641 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Drulis-Kawa Z, et al. 2011. Isolation and characterisation of KP34—a novel phiKMV-like bacteriophage for Klebsiella pneumoniae. Appl. Microbiol. Biotechnol. 90:1333–1345 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Halaby T, et al. 2012. A case of New Delhi metallo-beta-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae with putative secondary transmission from the Balkan region in the Netherlands. Antimicrob. Agents Chemother. 56:2790–2791 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Kutter E, et al. 2010. Phage therapy in clinical practice: treatment of human infections. Curr. Pharm. Biotechnol. 11:69–86 [DOI] [PubMed] [Google Scholar]
- 7. Leone I, Mungo E, Bisignano G, Chirillo MG, Savoia D. 2012. Klebsiella pneumoniae: emergence of multi-drug-resistant strains in Northwest Italy. J. Infect. 64:535–537 [DOI] [PubMed] [Google Scholar]
- 8. Lowe TM, Eddy SR. 1997. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 25:955–964 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Lukashin AV, Borodovsky M. 1998. GeneMark.hmm: new solutions for gene finding. Nucleic Acids Res. 26:1107–1115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Zdobnov EM, Apweiler R. 2001. InterProScan—an integration platform for the signature-recognition methods in InterPro. Bioinformatics 17:847–848 [DOI] [PubMed] [Google Scholar]